Biotech | October 15, 2021
Exelixis in-licenses second anti-cancer compound from Aurigene
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
In Western Europe, about 2% of procedures are done robotically while the majority, approximately 65%, are open surgery
This new lyophilizer is equipped with systems to best protect high value Active Pharmaceutical Ingredients (APIs) and doubles the lyophilization capacity at the site
The injection is used to reverse the effects of the muscle relaxants given to patients during surgery
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The rates for over 400 procedures were revised
More than 90,000 patients utilise the services daily
The consideration for the medicines in India is valued at Rs 180.48 crore
The state-of-the-art facility provides a pathway from development to large-scale biologics production
Subscribe To Our Newsletter & Stay Updated
